Prof Mariana Brandão, medical oncologist at Institute Jules Bordet, Hôpital...
Previously presented results of the phase III FLAURA-2 trial have demonstrated...
Previously presented results of the phase III FLAURA-2 trial have demonstrated...
The contemporary management of patients with stage III NSCLC has been one of...
One of the main talking points during the 2024 European Lung Cancer Conference...
The optimal management of stage III NSCLC continues to be a subject of intense...
The 2024 edition of ELCC featured the presentation of the new TNM...
During ELCC 2024, Dr Kristof Cuppens, pulmonologist and thoracic oncologist at...
Dr Karolien Vekens, pulmonologist at the University Hospital Brussels discusses...
Dr Anouk Goudsmit, medical oncologist at the Institut Jules Bordet in Brussels,...